WO1999048917A3 - Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung - Google Patents

Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung Download PDF

Info

Publication number
WO1999048917A3
WO1999048917A3 PCT/EP1999/001999 EP9901999W WO9948917A3 WO 1999048917 A3 WO1999048917 A3 WO 1999048917A3 EP 9901999 W EP9901999 W EP 9901999W WO 9948917 A3 WO9948917 A3 WO 9948917A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
specific protein
papilloma virus
production
approximately
Prior art date
Application number
PCT/EP1999/001999
Other languages
English (en)
French (fr)
Other versions
WO1999048917A2 (de
Inventor
Alexander Burger
Josef Gabelsberger
Original Assignee
Medigene Ag
Alexander Burger
Josef Gabelsberger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ag, Alexander Burger, Josef Gabelsberger filed Critical Medigene Ag
Priority to MXPA00009283A priority Critical patent/MXPA00009283A/es
Priority to AU35989/99A priority patent/AU3598999A/en
Priority to JP2000537899A priority patent/JP2002507625A/ja
Priority to EP99917850A priority patent/EP1066321A2/de
Priority to CA002323526A priority patent/CA2323526A1/en
Publication of WO1999048917A2 publication Critical patent/WO1999048917A2/de
Publication of WO1999048917A3 publication Critical patent/WO1999048917A3/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Die Erfindung betrifft eine Formulierung enthaltend mindestens ein Papillomavirus-spezifisches Protein mit ca. 0,3 bis ca. 4 M eines Salzes bei einem pH-Wert von ca. 7,3 bis ca. 7,45.
PCT/EP1999/001999 1998-03-24 1999-03-24 Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung WO1999048917A2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MXPA00009283A MXPA00009283A (es) 1998-03-24 1999-03-24 Fprmulacion con una proteina especifica del virus de papiloma, y la produccion y uso de esta.
AU35989/99A AU3598999A (en) 1998-03-24 1999-03-24 Formulation having a papilloma virus-specific protein, and the production and use thereof
JP2000537899A JP2002507625A (ja) 1998-03-24 1999-03-24 パピローマウイルス特異的タンパク質を含む配合物、その調製および使用
EP99917850A EP1066321A2 (de) 1998-03-24 1999-03-24 Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung
CA002323526A CA2323526A1 (en) 1998-03-24 1999-03-24 Formulation having a papilloma virus-specific protein, and the production and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812940.8 1998-03-24
DE19812940A DE19812940A1 (de) 1998-03-24 1998-03-24 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung

Publications (2)

Publication Number Publication Date
WO1999048917A2 WO1999048917A2 (de) 1999-09-30
WO1999048917A3 true WO1999048917A3 (de) 1999-12-09

Family

ID=7862147

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/001999 WO1999048917A2 (de) 1998-03-24 1999-03-24 Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung

Country Status (8)

Country Link
EP (1) EP1066321A2 (de)
JP (1) JP2002507625A (de)
AR (1) AR014969A1 (de)
AU (1) AU3598999A (de)
CA (1) CA2323526A1 (de)
DE (1) DE19812940A1 (de)
MX (1) MXPA00009283A (de)
WO (1) WO1999048917A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1213299A1 (de) * 2000-12-08 2002-06-12 Leids Universitair Medisch Centrum Immunogene epitopen des menschlichen Papillom-Virus und deren Anwendung
CA2431500C (en) 2000-12-08 2016-06-07 Sjoerd Hendrikus Van Der Burg Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
EP2363406B1 (de) * 2000-12-08 2019-02-27 Academisch Ziekenhuis Leiden Lange Peptide aus 22-45 Aminosäureresten, die die antigenspezifischen Immunreaktionen induzieren und/oder verbessern
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
WO1991018294A1 (en) * 1990-05-11 1991-11-28 Medscand Ab Synthetic peptides of human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunossay for diagnostic purposes
WO1996011272A2 (de) * 1994-10-07 1996-04-18 Medigene Gesellschaft Für Molekularbiologische Diagnostik, Theraphie Und Technologie Mbh Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4447664C2 (de) * 1994-10-07 1999-04-15 Lutz Prof Dr Gissmann Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
WO1991018294A1 (en) * 1990-05-11 1991-11-28 Medscand Ab Synthetic peptides of human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunossay for diagnostic purposes
WO1996011272A2 (de) * 1994-10-07 1996-04-18 Medigene Gesellschaft Für Molekularbiologische Diagnostik, Theraphie Und Technologie Mbh Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
JP2002507625A (ja) 2002-03-12
CA2323526A1 (en) 1999-09-30
DE19812940A1 (de) 1999-10-07
AU3598999A (en) 1999-10-18
WO1999048917A2 (de) 1999-09-30
EP1066321A2 (de) 2001-01-10
AR014969A1 (es) 2001-04-11
MXPA00009283A (es) 2002-12-13

Similar Documents

Publication Publication Date Title
AU2001244618A1 (en) Substituted 1,3-thiazole compounds, their production and use
PL338013A1 (en) Derivatives of condensed 1,2,4-thiadiazine, their production and application
AU5317596A (en) Emulsified, low ph cosmetic compositions having improved stability
ZA964710B (en) Novel compounds, the preparation and use thereof.
AU1378500A (en) Novel pyrimidines, the production thereof and their use
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
CA2262566A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
AU3053495A (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
AU3539199A (en) Novel 2,5-pyridinedicarboxylic acid derivatives
AU1380195A (en) The composition containing snapping turtle and tortoise, the preparation and the use thereof
WO1999048917A3 (de) Formulierung mit papillomavirus-spezifischem protein, seine herstellung und verwendung
HK1025782A1 (en) 1:2chromium complex dyes, the production and use thereof
AU6872896A (en) 4,4-difluoro-3-butenylester derivatives or 4,4-difluoro-3-halogen-3-butenylester derivatives and the use thereof as pesticides
DE59911666D1 (de) Kristallmodifikation b von 8-cyan- 1-cyclopropyl -7-(1s,6s-2, 8-diazabicyclo - 4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro- 4-oxo-3- chinolincarbonsaure
ZA200007636B (en) N-Phenyl-N'-Phenylpropylpiperazine derivatives and process for the preparation thereof.
AU4361696A (en) New uses of indolo-{2,3b}-quinoxalines
AU4122901A (en) Novel 7,8-dihydro-xanthenone-8-carboxylic acid derivative and novel microbe producing the same
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
AU1826697A (en) Single-component, aqueous, polyurea coating compositions
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AU6965398A (en) Preparation of thiazoles using 1,3-dihalopropenes
AU2645199A (en) Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methy lphosphonates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2323526

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2323526

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/009283

Country of ref document: MX

Ref document number: 09667553

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 35989/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999917850

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999917850

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999917850

Country of ref document: EP